Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 11, 2020

SELL
$8.12 - $13.12 $126,412 - $204,252
-15,568 Closed
0 $0
Q3 2019

Nov 01, 2019

SELL
$6.16 - $9.6 $30,800 - $48,000
-5,000 Reduced 24.31%
15,568 $107,000
Q2 2019

Jul 12, 2019

BUY
$8.12 - $15.72 $12,991 - $25,152
1,600 Added 8.44%
20,568 $190,000
Q1 2019

Apr 16, 2019

BUY
$15.58 - $20.01 $54,530 - $70,035
3,500 Added 22.63%
18,968 $297,000
Q4 2018

Jan 22, 2019

BUY
$14.59 - $23.84 $58,360 - $95,360
4,000 Added 34.88%
15,468 $239,000
Q1 2018

Apr 13, 2018

SELL
$16.68 - $22.07 $116,760 - $154,490
-7,000 Reduced 37.9%
11,468 $196,000
Q4 2017

Jan 23, 2018

SELL
$11.23 - $19.1 $61,765 - $105,050
-5,500 Reduced 22.95%
18,468 $276,000
Q3 2017

Oct 16, 2017

BUY
$15.41 - $32.17 $369,346 - $771,050
23,968
23,968 $422,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $23.3B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Northstar Group, Inc. Portfolio

Follow Northstar Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northstar Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Northstar Group, Inc. with notifications on news.